As far as newer names on the scene in the Canadian cannabis patch, Green Organic Dutchman Holdings Ltd (OTCMKTS: TGODF) has been gaining more and more attention. The stock hit the ground running and powered higher in late May and early June, pushing as much as 100% to the upside in just a couple weeks. We are now seeing a bit of a pullback to tap the 20-day rising exponential moving average as potential pivot support for technical traders looking for a retest of the $7.50 highs.
Contributing to that narrative, the company just announced it has entered into a strategic partnership with Epican Medicinals Ltd. According to the release, “this partnership will add an additional 14,000 kgs, taking TGOD’s total organic funded capacity to 130,000 kgs. Epican is a vertically integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licenses. This strategic partnership introduces TGOD’s premier organic cannabis brand to the international medical market.”
Green Organic Dutchman Holdings Ltd (OTCMKTS: TGODF) is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 116,000 kg and is building 970,000 sq. ft. of cultivation facilities in Ontario and Quebec.
The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 million for an approximate 17.5% stake in TGOD. In addition, the Company has raised approximately C$290 million dollars and has over 5,000 shareholders. TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
Find out when $TGODF stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
The chart shows 66% added to share values of the listing over the past month of action, but that move comes in the context of a larger bearish trend. Moreover, the company has seen interest climb, with an increase in recent trading volume of 22% beyond its prior sustained average level.
Karibe McKenize, CEO of Epican, stated “We are excited to partner with and benefit from TGOD’s immense knowledge in organic cannabis cultivation. This expertise supports and enhances our authentic Jamaican production and ensures patients receive a product that is completely free from chemical pesticides and synthetic fertilizers. Our partnership with TGOD solidifies our commitment to producing cannabis in the most sustainable and natural methods possible, honoring Jamaica’s historic relationship with the natural and medicinal benefits of the plant.”
“This is the first example of how we can partner with and introduce companies like CBx Technologies and Stillwater Brands to foreign jurisdictions,” said Csaba Reider, the Company’s President. “Through the development of GMP compliant, state-of-the-art extraction labs, TGOD will begin manufacturing these proven brands in international jurisdictions as regulations permit,” continued Mr. Reider.
At this time, carrying a capital value in the market of $1.08B, TGODF has a significant war chest ($100.5M) of cash on the books, which is balanced by about $46M total current liabilities. The company is pre-revenue at this point. We will update the story again soon as developments transpire. Sign-up for continuing coverage on shares of $TGODF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $TGODF, either long or short, and we have not been compensated for this article.